Celularity Inc
Biotechnology
Healthcare
CELU
22.55 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.16
52 week high
4.15
high
2.19
52 week low
0.00
low
2.08
growth
-26.85 %
previous Close
2.12
P/E ratio
-2
market cap
61.07 M
div yield
0
usd
Jun 2025
qoq
revenue
5.74 M
-68.37 %
net incoming
-24.52 M
-84.49 %
eps
-1.02 %
-70.17 %
eps surprise
0.00 %
net profit margin
-427.55 %
-354.00 %
operating incoming
-15.86 M
-70.95 %
net change in cash
632 K
-7.20 %
cash on hand
863 K
16.94 %
cost of revenue
5.24 M
-28.61 %
top top